Skip to content

Acupoint catgut embedding advantage in treating gastroesophageal reflux disease (ACE-GERD)

Acupoint catgut embedding advantage in treating gastroesophageal reflux disease (ACE-GERD)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074643
Enrollment
Unknown
Registered
2023-08-11
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroesophageal reflux disease

Interventions

Experimental group: The patients were positioned in a supine position and prone position. After routine disinfection, the polyglycolic acid absorbable sutures was implanted in the acupoints utilizing
Control group:Besides basic care, patients in the control group will be treated with sham ACE treatment that utilizing the same sterile disposable injection needles without polyglycolic acid absorbabl

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the study were as follows: (?) The diagnosis is consistent with gastroesophageal reflux disease and the duration of symptoms is greater than 4 weeks. (?) Patients were withdrawn from any medication known to adjust the gastrointestinal function for at least 2 weeks prior to the study. (?) Age 18–75 years old. (?) The consent form was signed by all subjects or a legal representative if the subject was not able to do so.

Exclusion criteria

Exclusion criteria: We excluded individuals based on the following criteria: (?) Pregnant or lactating women. (?) Patients with other comorbid conditions, such as a history of gastrointestinal surgery, gastrointestinal bleeding, severe heart and cerebrovascular diseases, liver and kidney insufficiency, as well as cachexia and tumor disease. (III) Patients with coagulopathy. (?) Patients suffering from spinal disorders. (V) Patients are allergic to absorbable sutures.

Design outcomes

Primary

MeasureTime frame
reflux disease questionnaire (RDQ) symptom score;

Secondary

MeasureTime frame
The gastroesophageal reflux disease questionnaire (GERDQ) score;Gastroesophageal reflux disease health-related quality of life (GERD-HRQL) score ;The Self-rating Anxiety Scale (SAS);The Self-rating Depression Scale (SDS);

Countries

China

Contacts

Public ContactShuting Wen

Guangdong Provincial Hospital of Traditional Chinese Medicine

20193109068@stu.gzucm.edu.cn+86 188 2640 4621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026